TY - GEN AU - Tanaka,Yasuhito TI - [Latest Treatment of Viral Hepatitis--Overcoming Hepatitis C and Reactivation of Hepatitis B] SN - 0047-1860 PY - 2016///0725 KW - Anilides KW - administration & dosage KW - Antineoplastic Agents KW - adverse effects KW - Antiviral Agents KW - Biomarkers KW - blood KW - Carbamates KW - Cyclopropanes KW - DNA, Viral KW - Drug Therapy, Combination KW - Hepatitis B KW - diagnosis KW - Hepatitis B Surface Antigens KW - Hepatitis B Vaccines KW - Hepatitis B virus KW - genetics KW - Hepatitis C KW - drug therapy KW - Humans KW - Imidazoles KW - Immunoassay KW - methods KW - Immunosuppressive Agents KW - Interferons KW - Interleukins KW - Isoquinolines KW - Lactams, Macrocyclic KW - Macrocyclic Compounds KW - Proline KW - analogs & derivatives KW - Pyrrolidines KW - Ritonavir KW - Rituximab KW - Sensitivity and Specificity KW - Sulfonamides KW - Transfusion Reaction KW - Valine KW - Virus Activation N1 - Publication Type: Journal Article; Review ER -